NEW YORK (GenomeWeb) – Quest Diagnostics this week announced that its board of directors approved a quarterly cash dividend of $.40 per share, payable on Oct. 19 to shareholders of record on Oct. 4.

Rubicon Genomics this week reported that its product sales rose 43 percent in the first half of 2016 from H1 2015. The company also announced the start of an early-access program for its new ThruPlex Tag-seq kits, which enable detection of low-frequency alleles with greater confidence. The program is available to both academic and commercial researchers.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.